Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Oct;115(7):203-18.
doi: 10.1042/CS20070430.

MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets

Anthony J Muslin  1
Affiliations
Review

MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets

Anthony J Muslin. Clin Sci (Lond). 2008 Oct.

Abstract

Intracellular MAPK (mitogen-activated protein kinase) signalling cascades probably play an important role in the pathogenesis of cardiac and vascular disease. A substantial amount of basic science research has defined many of the details of MAPK pathway organization and activation, but the role of individual signalling proteins in the pathogenesis of various cardiovascular diseases is still being elucidated. In the present review, the role of the MAPKs ERK (extracellular signal-regulated kinase), JNK (c-Jun N-terminal kinase) and p38 MAPK in cardiac hypertrophy, cardiac remodelling after myocardial infarction, atherosclerosis and vascular restenosis will be examined, with attention paid to genetically modified murine model systems and to the use of pharmacological inhibitors of protein kinases. Despite the complexities of this field of research, attractive targets for pharmacological therapy are emerging.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Model of the role of MAPK cascades in cardiomyocyte hypertrophy. In response to pressure overload, there is an intramyocardial release of ligands such as endothelin-1 (ET-1), angiotensin II (AngII) and norepinephrine (NE), growth factors such as fibroblast growth factor 1 (FGF1), and cytokines. These extracellular factors bind to and activate transmembrane G protein-coupled receptors (GPCR), receptor tyrosine kinases (RTK) and cytokine receptors (not depicted). Activated transmembrane receptors, in turn, directly activate intracellular signaling proteins, including G proteins (Gq/11) and the Grb2/SoS complex that promote activation of MAPK cascades and the Ca++/Calmodulin (CaM)-Calcineurin A (CnA)-NFAT3/4 cascade. Activation of these signaling cascades modulates the growth of cardiomyocytes in the manner depicted. Specifically, ERK MAPK phosphorylates a variety of targets that may contribute to cardiomyocyte growth, including the transcription factors Elk-1 and GATA4, and several proteins that regulate the translational machinery, including tuberin (TSC2 gene product), Mnk1 and p90RSK. On the other hand, JNK and p38 MAPK phosphorylate NFAT family members, resulting in inhibition of the calcineurin-NFAT hypertrophic pathway.
Figure 2
Figure 2
Model of the role of MAPK cascades in pathological cardiac remodeling after myocardial infarction. After myocardial infarction, there is a local release of ligands such as norepinephrine (NE), cytokines, growth factors such as FGF1, and reactive oxygen species (ROS) that leads to the activation transmembrane receptors and intracellular MAPK cascades. ROS may modify the activity of the MKKK ASK1 by blocking the ability of thioredoxin to inhibit ASK1. The activation of the MKKK-MKK3/6-p38α MAPK and the ASK1-MKK4/7-JNK1/2 cascades promotes pathological cardiac remodeling that includes cardiomyocyte apoptosis, inhibition of cardiomyocyte mitosis, inflammation and fibrosis. Specifically, p38α MAPK promotes cardiomyocyte mitosis by inhibiting the activity or expression of the anti-apoptotic proteins Bcl-2 and Bcl-xL.
Figure 3
Figure 3
Simplified model of macrophage foam cell formation in the arterial subintimal space. In response to vascular injury, monocytes are recruited to the intimal surface of arteries where they adhere and invade the vessel, differentiating into macrophages. In the subintimal space, macrophages are exposed to oxidized low density lipoprotein (oxLDL) that binds to the transmembrane protein CD36. Binding of oxLDL to CD36 triggers the activation of src-family kinases such as Lyn and MEKK2. Activation of Lyn and possibly MEKK2 leads to the activation of JNK2 and also p38α MAPK. Through largely undetermined mechanisms, activation of JNK2 and p38α MAPK promote the internalization of oxLDL either via CD36, scavenger receptor A (SR-A) or through other scavenger receptors. JNK2 promotes the phosphorylation of SR-A and this may lead to SR-A internalization while it is associated with modified LDL. Activation of MAPK cascades in macrophages may also modulate cholesterol efflux pathways.
Figure 4
Figure 4
Model of smooth muscle cell proliferation in neointima formation after vascular injury. In response to arterial injury that includes endothelial denudation and stretch, there is a local release of ligands such as endothelin-1 (ET-1), angiotensin II (AngII) and thrombin, growth factors (GFs), and cytokines that bind to transmembrane receptors. These receptors include G protein-coupled receptors (GPCRs), receptor tyrosine kinases (RTKs) and cytokine receptors (not depicted) that activate intracellular signaling proteins such as G proteins (Gq/11) and the Grb2/SOS complex. In turn, intracellular MAPK cascades are activated that ultimately leads to vascular smooth muscle cell migration (VSMC) into the intima and proliferation, resulting in neointima formation. The activation of p38α MAPK in vascular smooth muscle cells promotes the hyperphosphorylation of Rb and the expression of MCM6 that both contribute to cell proliferation.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ueno H, Colbert H, Escobedo JA, Williams LT. Inhibition of PDGF beta receptor signal transduction by coexpression of a truncated receptor. Science. 1991;252:844–848. - PubMed
    1. Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ullrich A, Skolnik EY, Bar-Sagi D, Schlessinger J. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell. 1992;70:431–442. - PubMed
    1. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature. 1993;363:45–51. - PubMed
    1. Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pelicci PG, et al. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature. 1992;360:689–692. - PubMed
    1. Buday L, Downward J. Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell. 1993;7:611–620. - PubMed

Publication types

MeSH terms

Substances

-